Free Trial

This company recently went public with an IPO on Tuesday, June 9th 2026. They issued 2,975,000 shares at $11.00 per share. We will continue to update data for ELOX as it becomes available.

Eloxx Pharmaceuticals (ELOX) Competitors

$14.70 +1.18 (+8.73%)
As of 04:00 PM Eastern
No competitors for Eloxx Pharmaceuticals were found.
Get Eloxx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELOX vs. The Competition

MetricEloxx PharmaceuticalsBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Industry SectorNASDAQ Exchange
Market Cap$9.31M$9.31M$2.86B$12.07B
Dividend YieldN/AN/A15.26%5.66%
P/E RatioN/AN/A14.9824.57
Price / Sales1.591.593,813.44141.49
Price / CashN/AN/A52.1537.92
Price / Book-0.17N/A5.926.78
Net Income-$5.99M-$5.99M-$220.64M$337.32M
7 Day PerformanceN/AN/A1.36%1.96%
1 Month Performance-30.58%-30.58%1.43%3.81%
1 Year PerformanceN/AN/A17.81%32.19%

Related Companies and Tools


This page (NASDAQ:ELOX) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners